RN

Ranganathan Nagarajan

Director Director DIN 08250148
DIN 08250148 First appointment Oct 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Ranganathan Nagarajan

Data last updated:

Ranganathan Nagarajan was a Director at Prism Life Sciences Limited (2018–2023) and Director at Expedient Technologies Limited (from 2020). The companies operate in Pharma.

DIN 08250148
Primary Designation Director
Industry Pharma
First Appointment 13 Oct 2018
Oldest Company Age 20 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Prism Life Sciences Limited U24230MH2002PLC137217
Director13 Oct 20182002₹36.89 Cr (FY 2025)Active
Expedient Technologies Limited U93090MH2006PLC163448
Director26 Feb 20202006Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Expedient Technologies Limited
Prism Life Sciences Limited
Premium access

Shareholding and investment profile for Ranganathan Nagarajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranganathan Nagarajan

Ranganathan Nagarajan was first appointed on 13 Oct 2018 as Director at Prism Life Sciences Limited. The most recent appointment on record is 26 Feb 2020 at Expedient Technologies Limited.

Ranganathan Nagarajan held 2 earlier board appointments: Prism Life Sciences Limited (Director, 13 Oct 2018 to 01 Jul 2023); Expedient Technologies Limited (Director, from 26 Feb 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available